Apella Raises $80 Million in Series B to Transform the Hospital with Ambient AI and Computer Vision

Apella, a health technology company, today announced it raised $80 million in Series B equity and venture debt. The round was led by HighlandX, with returning investors Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership, and Operator Partners, and includes new investors K2 HealthVentures, OpAmp Capital, and Houston Methodist. 

Previous
Previous

Kandu, Inc. Announces Appointment of Marshal Linder to Board of Directors and Strategic Growth Investment from K2 HealthVentures and Piper Sandler Merchant Bank

Next
Next

Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation